穆冰;宋一民;李晓斌;赵玉沛;

• 1:中国医学科学院北京协和医学院北京协和医院基本外科

摘要(Abstract)：

<正>胰岛移植被认为是1型糖尿病最有前景的治疗方法之一。若以生活质量改善及血糖控制为目标,胰岛移植的效果令人满意;但若以脱离外源胰岛素或预防并发症为目标,则前者差强人意,后者效果不明[1]。为此,美国糖尿病协会仍将胰岛移植定为实验阶段,距离临床应用尚有距离[2]。胰岛移植及面临的问题胰岛移植最早可以追溯至1972年的大鼠实验[3],此后逐渐开展,但成功率很低。一项对1990年至1999

关键词(KeyWords)： 胰岛移植;胰岛干细胞;1型糖尿病

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 穆冰;宋一民;李晓斌;赵玉沛;

Email:

DOI:

参考文献(References)：

• [1]Fiorina P,Shapiro A,Ricordi C,et al.The clinical impact of islet transplantation[J].Am J Transplantat,2008,8:1990-1997.
• [2]Robertson RP,Davis C,Larsen J,et al.Pancreas and islet transplantation in type 1 diabetes[J].Diabetes Care,2006,29:935.
• [3]Ballinger W,Lacy P.Transplantation of intact pancreatic islets in rats[J].Surgery,1972,72:175.
• [4]Brendel MD,Hering BJ,Schultz AO,et al.International islet transplant registry report[R/OL].(1999-08-22)[2013-04-15].http://www.med.uni-giessen.de/itr/newsletter/newsletter.htm.
• [5]Shapiro AJ,Lakey JR,Ryan EA,et al.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J].New Engl J Med,2000,343:230-238.
• [6]Shapiro AJ,Ricordi C,Hering BJ,et al.International trial of the Edmonton protocol for islet transplantation[J].New Engl J Med,2006,355:1318-1330.
• [7]Alejandro R,Barton FB,Hering BJ,et al.2008 Update from the collaborative islet transplant registry[J].Transplantation,2008,86:1783-1788.
• [8]Barton FB,Rickels MR,Alejandro R,et al.Improvement in outcomes of clinical islet transplantation:1999—2010[J].Diabetes Care,2012,35:1436-1445.
• [9]Deters NA,Stokes RA,Gunton JE.Islet transplantation:factors in short-term islet survival[J].Arch Immunol Ther Exp,2011,59:421-429.
• [10]Shapiro AJ.State of the art of clinical islet transplantation and novel protocols of immunosuppression[J].Curr Diab Rep,2011,11:345-354.
• [11]Jung HS,Choi SH,Kim SJ,et al.A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors[J].Clin Transplant,2007,21:738-743.
• [12]Hirshberg B.Can we justify living donor islet transplantation?[J].Curr Diab Rep,2006,6:307-309.
• [13]Groth C,Tibell A,Tollemar J,et al.Transplantation of porcine fetal pancreas to diabetic patients[J].Lancet,1994,344:1402-1404.
• [14]Heneine W,Tibell A,Switzer WM,et al.No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts[J].Lancet,1998,352:695-698.
• [15]Grose S.Critics slam Russian trial to test pig pancreas for diabetics[J].Nat Med,2007,13:390-391.
• [16]Narushima M,Kobayashi N,Okitsu T,et al.A humanβ-cell line for transplantation therapy to control type 1 diabetes[J].Nat Biotechnol,2005,23:1274-1282.
• [17]Ravassard P,Hazhouz Y,Pechberty S,et al.A genetically engineered human pancreaticβcell line exhibiting glucose-inducible insulin secretion[J].J Clin Invest,2011,121:3589.
• [18]Kroon E,Martinson LA,Kadoya K,et al.Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo[J].Nat Biotechnol,2008,26:443-452.
• [19]D'Amour KA,Bang AG,Eliazer S,et al.Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells[J].Nat Biotechnol,2006,24:1392-1401.
• [20]Kahan BW,Jacobson LM,Hullett DA,et al.Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells an in vitro model to study islet differentiation[J].Diabetes,2003,52:2016-2024.
• [21]McCall M,Toso C,Baetge E,et al.Are stem cells a cure for diabetes?[J].Clin Sci,2010,118:87-97.
• [22]Domínguez-Bendala J,Lanzoni G,Inverardi L,et al.Concise review:mesenchymal stem cells for diabetes[J].Stem Cells Transl Med,2012,1:59-63.
• [23]Reading JL,Sabbah S,Busch S,et al.Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation[J].Curr Opin Organ Transplant,2013,18:59-64.
• [24]Tang DQ,Wang Q,Burkhardt BR,et al.In vitro generationof functional insulin-producing cells from human bone marrowderived stem cells,but long-term culture running risk of malignanttransformation[J].Am J Stem Cells,2012,1:114.
• [25]Vija L,Farge D,Gautier JF,et al.Mesenchymal stem cells:stem cell therapy perspectives for type 1 diabetes[J].Diabetes Metab,2009,35:85-93.
• [26]Lv S,Cheng J,Sun A,et al.Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress[J].Diabetes Res Clin Pract,2014,104:143-154.
• [27]Wang S,Li Y,Zhao J,et al.Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model[J].Biol Blood Marrow Transplant,2013,19:538-546.
• [28]Yang Z,Li K,Yan X,et al.Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats[J].Graefes Arch Clin Exp Ophthalmol,2010,248:1415-1422.
• [29]Kuo YR,Wang CT,Cheng JT,et al.Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes[J].Plast Reconstr Surg,2011,128:872-880.
• [30]Maharlooei MK,Bagheri M,Solhjou Z,et al.Adipose tissue derived mesenchymal stem cell(AD-MSC)promotes skin wound healing in diabetic rats[J].Diabetes Res Clin Pract,2011,93:228-234.
• [31]Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].Cell,2006,126:663-676.
• [32]Alipio Z,Liao W,Roemer EJ,et al.Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem(iPS)-derived pancreaticβ-like cells[J].Proc Natl Acad Sci USA,2010,107:13426-13431.
• [33]Stadtfeld M,Nagaya M,Utikal J,et al.Induced pluripotent stem cells generated without viral integration[J].Science,2008,322:945-949.
• [34]Golestaneh N,Kokkinaki M,Pant D,et al.Pluripotent stem cells derived from adult human testes[J].Stem Cells Dev,2009,18:1115-1125.
• [35]Kobayashi T,Yamaguchi T,Hamanaka S,et al.Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells[J].Cell,2010,142:787-799.
• [36]Ber I,Shternhall K,Perl S,et al.Functional,persistent,and extended liver to pancreas transdifferentiation[J].J Biol Chem,2003,278:31950-31957.
• [37]Yang LJ.Liver stem cell-derivedβ-cell surrogates for treatment of type 1 diabetes[J].Autoimmun Rev,2006,5:409-413.
• [38]Zhou Q,Brown J,Kanarek A,et al.In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J].Nature,2008,455:627-632.
• [39]Yang YP,Thorel F,Boyer DF,et al.Context-specificα-to-β-cell reprogramming by forced Pdx1 expression[J].Genes Dev,2011,25:1680-1685.
• [40]Wang R,Klppel G,Bouwens L.Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats[J].Diabetologia,1995,38:1405-1411.
• [41]Dor Y,Brown J,Martinez OI,et al.Adult pancreaticβ-cells are formed by self-duplication rather than stem-cell differentiation[J].Nature,2004,429:41-46.
• [42]Furuyama K,Kawaguchi Y,Akiyama H,et al.Continuous cell supply from a Sox9-expressing progenitor zone in adult liver,exocrine pancreas and intestine[J].Nat Genet,2011,43:34-41.